In calves, IgA and IgM can be detected since eight days after bRSV challenge (102), and protection from respiratory disease has been achieved after vaccination with a mucosal polyanhydride nanovaccine by inducing significant levels of RSV-specific IgA in nasal secretion and BAL, as well as cellular responses in airways and peripheral blood (51). Here, CD79A is linked to respiratory system disorder.